Skip to main content
Erschienen in: Journal of Cancer Education 2/2019

23.11.2017

Age-Specific Patient Navigation Preferences Among Adolescents and Young Adults with Cancer

verfasst von: Samantha T. Pannier, Echo L. Warner, Brynn Fowler, Douglas Fair, Sara K. Salmon, Anne C. Kirchhoff

Erschienen in: Journal of Cancer Education | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Patient navigation is increasingly being directed at adolescent and young adult (AYA) patients. This study provides a novel description of differences in AYA cancer patients’ preferences for navigation services by developmental age at diagnosis.

Methods

Eligible patients were diagnosed with cancer between ages 15 and 39 and had completed at least 1 month of treatment. Between October 2015 and January 2016, patients completed semi-structured interviews about navigation preferences. Summary statistics of demographic and cancer characteristics were generated. Differences in patient navigation preferences were examined through qualitative analyses by developmental age at diagnosis.

Results

AYAs were interviewed (adolescents 15–18 years N = 8; emerging adults 19–25 years N = 8; young adults 26–39 years N = 23). On average, participants were 4.5 years from diagnosis. All age groups were interested in face-to-face connection with a navigator and using multiple communication platforms (phone, text, email) to follow-up. Three of the most frequently cited needs were insurance, finances, and information. AYAs differed in support, healthcare, and resource preferences by developmental age; only adolescents preferred educational support. While all groups preferred financial and family support, the specific type of assistance (medical versus living expenses, partner/spouse, child, or parental assistance) varied by age group.

Conclusions

AYAs with cancer have different preferences for patient navigation by developmental age at diagnosis. AYAs are not a one-size-fits-all population, and navigation programs can better assist AYAs when services are targeted to appropriate developmental ages. Future research should examine fertility and navigation preferences by time since diagnosis. While some navigation needs to span the AYA age range, other needs are specific to developmental age.
Literatur
1.
Zurück zum Zitat National Cancer Institute and the LiveStrong Young Adult Alliance (2006) Closing the gap: research and care imperatives for adolescents and young adults with cancer. Report of the adolescent and young adult oncology program review group. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, LIVESTRONG Young Adult Alliance. Available at: https://www.cancer.gov/types/aya/research/ayao-august-2006.pdf National Cancer Institute and the LiveStrong Young Adult Alliance (2006) Closing the gap: research and care imperatives for adolescents and young adults with cancer. Report of the adolescent and young adult oncology program review group. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, LIVESTRONG Young Adult Alliance. Available at: https://​www.​cancer.​gov/​types/​aya/​research/​ayao-august-2006.​pdf
5.
Zurück zum Zitat Bleyer A Young adult oncology: the patients and their survival challenges. CA Cancer J Clin 57:242–255 Bleyer A Young adult oncology: the patients and their survival challenges. CA Cancer J Clin 57:242–255
9.
Zurück zum Zitat Reed D, Block RG, Johnson R (2014) Creating an adolescent and young adult cancer program: lessons learned from pediatric and adult oncology practice bases. J Natl Compr Cancer Netw 12:1409–1415CrossRef Reed D, Block RG, Johnson R (2014) Creating an adolescent and young adult cancer program: lessons learned from pediatric and adult oncology practice bases. J Natl Compr Cancer Netw 12:1409–1415CrossRef
12.
Zurück zum Zitat Arnett JJ (2001) Conceptions of the transition to adulthood: perspectives from adolescence through midlife. J Adult Dev 8 Arnett JJ (2001) Conceptions of the transition to adulthood: perspectives from adolescence through midlife. J Adult Dev 8
18.
20.
Zurück zum Zitat Saldaña J (2013) The coding manual for qualitative researchers, 2nd edn. Sage, Los Angeles Saldaña J (2013) The coding manual for qualitative researchers, 2nd edn. Sage, Los Angeles
23.
Zurück zum Zitat Lang M, Giese-Davis J, Patten S, Campbell DJT (2017) Does age matter? Comparing post-treatment psychosocial outcomes in young adult and older adult cancer survivors with their cancer-free peers. Psychooncology. https://doi.org/10.1002/pon.4490 Lang M, Giese-Davis J, Patten S, Campbell DJT (2017) Does age matter? Comparing post-treatment psychosocial outcomes in young adult and older adult cancer survivors with their cancer-free peers. Psychooncology. https://​doi.​org/​10.​1002/​pon.​4490
26.
Zurück zum Zitat Mathews TJ, Hamilton BE (2016) Mean age of mothers is on the rise: United States, 2000–2014. NCHS data brief, no 232. Hyattsville: National Center for Health Statistics Mathews TJ, Hamilton BE (2016) Mean age of mothers is on the rise: United States, 2000–2014. NCHS data brief, no 232. Hyattsville: National Center for Health Statistics
Metadaten
Titel
Age-Specific Patient Navigation Preferences Among Adolescents and Young Adults with Cancer
verfasst von
Samantha T. Pannier
Echo L. Warner
Brynn Fowler
Douglas Fair
Sara K. Salmon
Anne C. Kirchhoff
Publikationsdatum
23.11.2017
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2019
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-017-1294-4

Weitere Artikel der Ausgabe 2/2019

Journal of Cancer Education 2/2019 Zur Ausgabe

Resektabler Speiseröhrenkrebs: FLOT schlägt CROSS

13.06.2024 ASCO 2024 Kongressbericht

Die perioperative Chemotherapie mit dem FLOT-Regime verbessert gegenüber der neoadjuvanten Radiochemotherapie mit CROSS das Gesamtüberleben von Patientinnen und Patienten mit resektablen Adenokarzinomen der Speiseröhre. Das legen aktuelle Daten der ESOPEC-Studie nahe.

Wo Künstliche Intelligenz in der Onkologie eingesetzt wird

12.06.2024 ASCO 2024 Kongressbericht

Wie lässt sich mit Künstlicher Intelligenz die Krebsversorgung voranbringen? Drei Beispiele vom ASCO-Kongress zeigen, wo es funktionieren kann: bei der Risikoabschätzung, der Vorhersage des Therapie-Ansprechens und beim telefonischen Kontakt mit Patientinnen und Patienten.

HPV-Impfung schützt auch Männer vor Krebs

12.06.2024 ASCO 2024 Kongressbericht

Die HPV-Impfung wird für Mädchen wie Jungen vorrangig empfohlen, um Zervixkarzinome bei Frauen zu verhindern. Doch auch andere HPV-assoziierte Krebserkrankungen werden reduziert.

Neuer Therapiestandard für das Multiple Myelom?

12.06.2024 ASCO 2024 Kongressbericht

Erstmals wurde die zusätzliche Gabe von Isatuximab zum VRd-Schema in einer Phase-III-Studie bei nicht-transplantationsfähigen Patienten mit neu diagnostiziertem Multiplem Myelom mit VRd verglichen – so erfolgreich, dass sich möglicherweise ein neuer Standard abzeichnet.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.